Ascendis Pharma A/S Gains 21.37%
Thu, Aug 26, 2021 at 05:32 PM
Ascendis Pharma A/S (ASND:NASDAQ) soared at $149.7, representing a gain of 21.4%. On Wed, Aug 25, 2021, ASND:NASDAQ hit a New 2-Week High of $123.67. The stock got featured on our News Catalysts scanner on Thu, Aug 26, 2021 at 02:15 PM in the 'BIOTECH' category. From Wed, Aug 11, 2021, the stock recorded 50.00% Up Days and 45.45% Green Days
The share price of the company has been moving sideways in recent weeks.
About Ascendis Pharma A/S (ASND:NASDAQ)
Ascendis Pharma A/S is a biotechnology company that applies its TransCon technology to develop a pipeline of prodrug therapies with profiles that address markets with unmet medical needs.
Top 10 Gainers:
- LWAC (LWAC:NASDAQ), 92.95%
- Glory Star New Media Group Holdings Limited (GSMG:NASDAQ), 50.97%
- Support.com, Inc. (SPRT:NASDAQ), 41.12%
- TSR, Inc. (TSRI:NASDAQ), 28.06%
- SGOCO Group, Ltd. (SGOC:NASDAQ), 27.5%
- LGL Systems Acquisition Corp. (DFNS:NYSE), 26.85%
- GAMB (GAMB:NASDAQ), 23.73%
- Ascendis Pharma A/S (ASND:NASDAQ), 21.37%
- JWEL (JWEL:NASDAQ), 19.57%
- Zomedica Pharmaceuticals Corp. (ZOM:NYSEMKT), 18.96%